Publication date: Available online 3 November 2026 Source: JHEP Reports Author(s): Alexandra Wolf, Matias Facciuto, Melissa Damiecki, Emily R. Bramel, Eric Park, Sara E. Young, Miguel Torres, Shalini Nath, Vincenzo Mazzaferro, Myron Schwartz, Amaia Lujambio, Benjamin D. Hopkins, Alexander M. Tsankov, Anna Tocheva, Daniela Sia
A novel preclinical platform to study FGFR2 fusion-driven cholangiocarcinoma☆. // JHEP Reports. – URL: https://www.sciencedirect.com/science/article/pii/S2589555926003617?dgcid=rss_sd_all
A novel preclinical platform to study FGFR2 fusion-driven cholangiocarcinoma☆. JHEP Reports. https://www.sciencedirect.com/science/article/pii/S2589555926003617?dgcid=rss_sd_all
“A novel preclinical platform to study FGFR2 fusion-driven cholangiocarcinoma☆.” JHEP Reports.
@article{article51171,
title = {A novel preclinical platform to study FGFR2 fusion-driven cholangiocarcinoma☆},
journal = {JHEP Reports},
url = {https://www.sciencedirect.com/science/article/pii/S2589555926003617?dgcid=rss_sd_all}
}
Abstract Background Macrophage polarisation plays a crucial role in sepsis‐associated inflammatory responses; however, the underlying molecular regulatory mechanisms remain to be further explored. Aim This study aimed to explore the...